| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/17/2001 | US6261561 Administering intimin or fusion protein |
| 07/17/2001 | US6261560 Method for inhibiting muscle protein proteolysis with antibodies to interleukin-6 receptor |
| 07/17/2001 | US6261559 Inhalation device |
| 07/17/2001 | US6261558 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 07/17/2001 | US6261535 Images of tumors |
| 07/17/2001 | CA2126182C Humanized antibodies reactive with gpiib/iiia |
| 07/17/2001 | CA2110519C Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits detection of bovine herpesvirus type 1 |
| 07/17/2001 | CA2055615C Monoclonal antibodies for inducing tolerance |
| 07/17/2001 | CA2034197C Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
| 07/12/2001 | WO2001049866A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 07/12/2001 | WO2001049859A1 Trichoderma reesei xylanase |
| 07/12/2001 | WO2001049845A1 Growth factor splice variant |
| 07/12/2001 | WO2001049838A2 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone 3'-untranslated region |
| 07/12/2001 | WO2001049828A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
| 07/12/2001 | WO2001049823A2 Assays for detection of bacillus anthracis |
| 07/12/2001 | WO2001049745A1 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 07/12/2001 | WO2001049740A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | WO2001049729A2 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use |
| 07/12/2001 | WO2001049720A2 Chemically modified hiv envelope glycoprotein |
| 07/12/2001 | WO2001049715A2 Methods and compositions for inhibiting neoplastic cell growth |
| 07/12/2001 | WO2001049713A2 Stabilizing peptides, polypeptides and antibodies which include them |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049710A2 Method for identifying substances which mimic mammal epitopes |
| 07/12/2001 | WO2001049321A1 Tnf inhibitors for the treatment of neurological, retinal and muscular disorders |
| 07/12/2001 | WO2001049163A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | WO2001012665A3 Helical cytokine zalpha48 |
| 07/12/2001 | WO2001004281A3 Dna coding for beta-tubulin and use thereof |
| 07/12/2001 | WO2001004151A3 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 07/12/2001 | WO2001002588A3 Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests |
| 07/12/2001 | WO2000075278A9 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
| 07/12/2001 | WO2000074722A3 Modification of biological elements |
| 07/12/2001 | WO2000056144A9 Human sperm surface antigen |
| 07/12/2001 | WO2000034447A8 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 07/12/2001 | WO2000004041A3 Methods and molecules relating to cd39-like polypeptides |
| 07/12/2001 | WO2000000510A3 Growth factor modulators |
| 07/12/2001 | WO1999052541A3 Artery- and vein-specific proteins and uses therefor |
| 07/12/2001 | US20010007755 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/12/2001 | US20010007660 Methods of treating and protecting against tuberculosis using a monoclonal antibody selective for mycobacterium tuberculosis |
| 07/12/2001 | DE19963859A1 Bi- oder Oligomer eines Di-, Tri-, Quattro- oder Pentamers von rekombinanten Fusionsproteinen Bi- or oligomer of a di-, tri-, Quattro or pentamer of recombinant fusion proteins |
| 07/12/2001 | DE19963126A1 Verfahren zur Herstellung von 6-O-alpha-D-Glucopyranosyl-D-sorbit A process for the preparation of 6-O-alpha-D-glucopyranosyl-D-sorbitol |
| 07/12/2001 | DE19960500A1 Antikörper und Verfahren zu ihrer Herstellung, deren Verwendung sowie Immunisierungscocktails, Immunoassay-Sets und Peptide Antibodies and methods for their preparation, their use and immunization cocktails, immunoassay kits and peptides |
| 07/12/2001 | CA2402131A1 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 07/12/2001 | CA2396696A1 Assays for detection of bacillus anthracis |
| 07/12/2001 | CA2396401A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | CA2396173A1 Chemically modified hiv envelope glycoprotein |
| 07/12/2001 | CA2395991A1 Method for identifying substances which mimic mammal epitopes |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | CA2395198A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | CA2395041A1 Stabilizing peptides, polypeptides and antibodies which include them |
| 07/12/2001 | CA2394730A1 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use |
| 07/11/2001 | EP1114864A2 Mammalian cell surface antigens, related reagents |
| 07/11/2001 | EP1114863A2 Heregulins (HRGs), binding proteins of P185erb2 |
| 07/11/2001 | EP1114862A2 Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases and their use in indentifying pharmacologically acitve substances |
| 07/11/2001 | EP1114322A1 Tandem immuno-assay for cancer |
| 07/11/2001 | EP1114164A1 Atp synthase subunit homolog |
| 07/11/2001 | EP1114160A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
| 07/11/2001 | EP1114159A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |
| 07/11/2001 | EP1114157A2 Regulatory protein from human keratinocytes |
| 07/11/2001 | EP1114156A2 Mammalian transforming growth factor beta - 9 (ztgfss9) |
| 07/11/2001 | EP1114154A2 Compositions and methods for the treatment of immune related diseases |
| 07/11/2001 | EP1114153A2 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses therof |
| 07/11/2001 | EP1114152A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/11/2001 | EP1114145A1 Topa |
| 07/11/2001 | EP1114143A1 Streptococcal c beta protein compositions |
| 07/11/2001 | EP1114064A1 A monoclonal antibody against estrogen stimulated leucine aminopeptidase |
| 07/11/2001 | EP1113818A1 METHODS OF TREATING IgE-ASSOCIATED DISORDERS AND COMPOSITIONS FOR USE THEREIN |
| 07/11/2001 | EP1113817A1 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies |
| 07/11/2001 | EP1113812A1 Method and compositions for preventing or reducing hiv infection by use of inhibitors for leucine aminopeptidase |
| 07/11/2001 | EP1113810A2 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 07/11/2001 | EP0820489B1 Hybrid phthalocyanine derivatives and their uses |
| 07/11/2001 | EP0600018B1 Hepatitis c assay utilizing recombinant antigens to c-100 region |
| 07/11/2001 | CN1303435A TAO protein kinases and methods of use therefor |
| 07/11/2001 | CN1303431A Humanized antibody against human tissue factor (TF) and process for constructing humanized antibody |
| 07/11/2001 | CN1303430A FAP alpha specific antibody with improved producibility |
| 07/11/2001 | CN1303393A Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 07/11/2001 | CN1303392A Method for separating and/or isolating plasma proteins by annularchromatography |
| 07/11/2001 | CN1303301A Use of anti-gp 39 antibodies for treatment and/or reversal of lupus and associated kidney disease |
| 07/11/2001 | CN1303300A Isolated peptides corresponding to amino acid sequences of NY-ESO-1, wherein bind to MHC class I and MHC class II molecules, and uses thereof |
| 07/11/2001 | CN1303299A Method and compositions for peptide synthesis |
| 07/11/2001 | CN1302899A 人蛋白酪氨酸磷酸酶及其编码序列 Human protein tyrosine phosphatase and its coding sequence |
| 07/11/2001 | CN1302898A Polypeptide-human phosphatidase 14 and polynucleotide for coding it |
| 07/11/2001 | CN1302894A Polypeptide-human dehydrogenase 35 and polynucleotide for coding it |
| 07/11/2001 | CN1302893A Polypeptide-human RNA uncoiling enzyme 44 and polynucleotide for coding it |
| 07/11/2001 | CN1302892A Polypeptide-human chondriosome acyl-CoA thioesterase 48 and polynucleotide for coding it |
| 07/11/2001 | CN1302889A Polypeptide-human protein 70 containing plasmolemma regulation function and polynucleotide for coding it |
| 07/11/2001 | CN1302888A Polypeptide-human rigor factor 23 and polynucleotide for coding it |
| 07/11/2001 | CN1302887A Polypeptide-dyein light-medium chain 58 and polynucleotide for coding it |
| 07/11/2001 | CN1302884A Polypeptide-human eukaryote initiation factor 50 and polynucleotide for coding it |
| 07/11/2001 | CN1302883A Polypeptide-human enameling protein 23 and polynucleotide for coding it |
| 07/11/2001 | CN1302882A Polypeptide-human ankyrin 27 and polynucleotide for coding it |
| 07/11/2001 | CN1302879A Polypeptide-human F-actin binding factor 75 and polynucleotide for coding it |
| 07/11/2001 | CN1302814A Polypeptide-human S18 ribosomal protein 18 and polynucleotide for coding it |
| 07/11/2001 | CN1302813A Polypeptide-zinc finger protein 42 and polynucleotide for coding it |
| 07/11/2001 | CN1302802A Human gamma-globuline affinity ligand and its use |
| 07/11/2001 | CA2331012A1 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/10/2001 | US6258939 Hybridoma which produces monoclonal antibody which binds prostate stem cell antigen; accurate/early diagnosis of cancer/tumors; immunotherapy |
| 07/10/2001 | US6258938 Using antibody immobilized to solid support to bind protein complexed with metal cation, contacting complex with compound having higher binding affinity for cation than protein to induce destabilized conformational state and release protein |
| 07/10/2001 | US6258937 Hepadnavirus receptor |
| 07/10/2001 | US6258936 SpoIIIE |